Rhizoma drynariae is the main traditional Chinese medicine used for the treatment of osteoporosis, but its anti-osteoporotic targeting mechanism has not been fully elucidated due to the complexity of its active ingredients. In this study, the pharmacological mechanism of action of Rhizoma drynariae against osteoporosis was studied by integrating pharmacological concepts. The pharmacokinetic characteristics of selected major active constituents of Rhizoma drynariae and the SMILES structural similarity were used to predict related targets. A literature search was conducted to identify known osteoporosis treatment targets, which were then combined with the predicted targets to construct the direct or indirect target interaction network map of Rhizoma drynariae against osteoporosis. Finally, data on the key targets of the interactions, ranked according to relevant node parameters obtained through pathway enrichment analysis and screening of key targets and active ingredients of Rhizoma drynariae, were used to perform molecular docking simulation. We screened 16 active ingredients of Rhizoma drynariae, and 7 key targets with direct or indirect effects with a high frequency were obtained. These main pathways were found to play important roles in the PI3k-akt signaling pathway, osteoclast differentiation, Wnt signaling pathway, and estrogen signaling pathway. Molecular docking showed that most active ingredients of Rhizoma drynariae had strong binding efficiency with key targets. Based on network pharmacology, we conclude that Rhizoma drynariae plays an anti-osteoporotic role by directly or indirectly targeting multiple major signaling pathways and influencing the proliferation and differentiation of multiple types of cells.
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Background
Osteoporosis (OP) is a systemic bone disease that involves decreased bone density and bone quality. The destruction of the bone microstructure and an increase in bone fragility eventually lead to an increase of fracture risk and pose a serious threat to the health of middle-aged and elderly people [1] . In terms of pathogenesis, osteogenesis-osteoclast coupling is unbalanced, with increased osteoclasts, increased lipogenesis, and decreased osteogenesis, which are closely related to proliferation and differentiation of bone marrow mesenchymal stem cells (BMSCs), hematopoietic stem cells, osteoblasts, osteoclasts, adipocytes and other cells, and involves multiple systems such as osteogenesis, hematopoiesis, and immunity. The pathogenesis of OP is complex, and there is interaction and crossover between OP and a variety of related signaling pathways. At present, conventional anti-osteoporotic drugs have disadvantages such as targeting only a single target, poor efficacy, and serious adverse effects [2] . Therefore, an increasing number of scholars are paying attention to research on the prevention and treatment of osteoporosis using traditional Chinese medicine [3] .
Traditional Chinese medicine contains a large number of ingredients and uses extremely complex mechanisms to intervene in the progression of disease. Rhizoma drynariae, from the Drynaria fortunei dry rhizome, is a traditional Chinese medicine commonly used in orthopedics departments and widely used in the treatment of osteoporosis. Although previous studies have confirmed the efficacy of Rhizoma drynariae in treating OP [4, 5] , since its ingredients are complex and its action targets numerous, it is difficult to fully elucidate its mechanism of action. Therefore, it is necessary to study the biological processes of drug, gene, and protein interactions at a systematic level to reveal the molecular mechanisms related to the efficacy of TCM (Figure 1 ).
In recent years, along with continuous innovation and the development of systems biology, network pharmacology, and computer technology, it can be seen that network pharmacology has a wide applicational value in many fields, such as drug-target identification, the discovery of effective ingredients, research on the mechanism of action, preclinical study of drug efficacy, and safety evaluation [6] . We sought to further assess the anti-osteoporotic mechanism of Rhizoma drynariae, to assist in development of new drugs, and to improve conventional anti-osteoporosis drug treatments for OP defects and bottlenecks. We based our study on the concepts of network pharmacology, data searching, and data mining through the establishment of screening for Rhizoma drynariae active ingredients and the osteoporosis targets of the protein-protein interaction (PPI) network diagram.
Material and Methods

Screening for active ingredients of Rhizoma drynariae
According to the parameters of ADME (absorption, distribution, metabolism, excretion) [7, 8] , we screened for the active ingredients of Rhizoma drynariae by searching the pharmacological database of the traditional Chinese medicine system and analyzing platforms (TCMSP) (http://ibts.hkbu. edu.hk/LSP/tcmsp. php) [9] , last updated on 2014-05-31. The screening conditions were oral bioavailability (OB) greater than 30% and drug similarity (DL) greater than 0.18 [10, 11] . A total of 16 active ingredients and their corresponding typical SMILES structures were obtained by searching relevant literature and the PubChem network database (https://pubchem.ncbi.nlm.nih. gov/) [12] .
Prediction of targets of the active ingredients in Rhizoma drynariae
The SMILES structures of ingredients obtained from PubChem were imported into the Prediction Target of Swiss Target Prediction network database (http://www.swisstargetprediction.ch/) [13] . Predictions can be carried out using 5 marker organisms, and predictions can be mapped using the principle of homology, within and between different species for close paralogs and orthologs. To improve prediction accuracy, only 118 predicted targets with high probability were selected and duplicates were deleted. After importing the 118 targets into the Therapeutic Target Database (TTD) (http://bidd.nus. edu.sg/group/cjttd/), Comparative Toxicogenomics Database (CTD) (http://ctdbase.org/), and PharmGKB (https://www.pharmgkb.org/), the disease target network database was used to verify whether they were related to osteoporosis. Then, Gene Ontology (GO) enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG) network pathway analysis were performed on the targets obtained. Cytoscape [14] was used to construct Compound Target and Compound Pathway network maps for this data.
Targets associated with osteoporosis
The Online Mendelian Inheritance in Man (OMIM) [15] , PubMed, and other databases were used to search for relevant research reports, and all known targets related to osteoporosis were found. "Osteoporosis" was used as the keyword to search and screen for OP-related targets, and known targets in the pathogenesis of OP were obtained. Since target names in each database are irregular, official symbols were converted into Uniprot IDs for subsequent analysis. Then, the OP related targets were imported into the DAVID database (http://david. abcc.ncifcrf.gov version 6.7) for GO enrichment and KEGG network pathway analysis.
Establishing a T-T network
PPI network mapping was performed on obtained bioactive ingredients and disease targets using BisoGenet software. Then, Cytoscape was used to fuse and extract the intersection of the 2 network graphs drawn, so as to obtain a direct and an indirect target-target regulatory network graph of Rhizoma drynariae treatment of OP. Again, along with the analysis of network topology obtained using the CytoNCA [16] plug-in and literature, indicators such as the degree of centricity (DC), medium degree centrality (BC), close to the central (CC), the eigenvector centrality (EC), the network centricity (NC), and local edge connectivity topology selection (LAC) were used. Where nodes with a DC value greater than 2 times the median DC value of all nodes [17] are important nodes in the network, the nodes whose other indexes are larger than the median of all nodes are termed "Big hubs" [18] . To obtain more node information and higher node information transfer efficiency in the network as much as possible, the direct or indirect targets or mechanisms of the anti-osteoporotic effects of Rhizoma drynariae were further explored. The PPI network was constructed for the hub nodes obtained through the String database (https:// string-db.org/) [19] . At the same time, GO enrichment and KEGG pathway analysis were also conducted. After extensive pathways were excluded, the top 20 signaling pathways related to osteoporosis were screened out.
Molecular docking
To further screen for the most active interactions between the active ingredients of Rhizoma drynariae and the key nodes, the reliability of this study was verified through computer simulation docking technology. To obtain the SDF structure of active ingredients from the PubChem database (https://pubchem. ncbi.nlm.nih.gov/), data were imported into the SystemsDock online docking software (http://systemsdock.unit.oist.jp/) [20] for molecular docking simulation.
Results
Screening of active ingredients of Rhizoma drynariae
A total of 71 reported active ingredients of Rhizoma drynariae were retrieved by searching the TCMSP database, and 18 of these bioactive ingredients were preliminarily screened out 
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using ADME parameters such as OB and DL. After finding the relevant structure and target data from PubChem and the Swiss Target Prediction database, 16 active ingredients with corresponding targets were obtained after final screening, as shown in Table 1 . Most of the selected active ingredients are flavonoids such as naringin, (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl) chroman-4-one, kaempferol, eriodictyol, luteolin, and a small amount of lignans and steroids such as b-sitosterol. Most of these ingredients possess potent pharmacological activity. For example, b-sitosterol has good anti-oxidation and anti-inflammatory effects [21, 22] , luteolin has antibacterial, anti-oxidant, and other broad biological and pharmacological properties [23] , and kaempferol has an anti-inflammatory effect [24] , and naringenin was determined to be the quality markers of Rhizoma drynariae in the Chinese Pharmacopoeia (the State Pharmacopoeia Commission of China, 2015). The OB of these compounds varies greatly, presenting an approximately normal distribution, mostly concentrated at about 40%, and the OB is generally inversely proportional to the molecular weight (MW).
The lower the MW, the higher the OB is. The route of administration of most drugs is oral. In addition to OB, the intestinal epithelial permeability (Caco-2) of the drug plays an important role in its efficacy. Overall, the higher the DL, the higher the Caco-2, such as Stigmasterol DL: 1.76, Caco-2: 1.44, luteolin DL: 0.25, and Caco-2: 0.19.
The putative target of active ingredients of Rhizoma drynariae
Swiss Target Prediction was used to predict the targets of 16 chemical ingredients of Rhizoma drynariae, and a total of 118 targets were obtained after high-possibility screening and de-duplication. We found that 50 of the 118 putative targets were common to 2 or more of these ingredients, suggesting that these ingredients act on some of the same biological processes or pathways, which reflects the synergistic effect of multiple ingredients on bone fractionation, and the targets also play an important role in the entire pathogenesis of OP. The Compound target network is shown in Figure 2 . Figure 3 shows the 32 KEGG enriched signaling pathways and the constructed Target-Pathway network.
OP-related targets
By searching the OMIM and PubMed databases for related research reports, we obtained 95 and 256 targets, respectively, which are closely related to the occurrence and development of OP. A total of 316 targets were screened after double checking and removal of false-positive information. Since database names are irregular, the official symbol was converted into Uniprot IDs for use in subsequent analyses. Then, the obtained OP-related targets were imported into the DAVID database for GO enrichment and KEGG network pathway analysis.
By excluding a wide range of pathways from KEGG enrichment results, the following top 10 signal transduction pathways were selected: PI3K-Akt signaling pathway, osteoclast differentiation, MAPK signaling pathway, TNF signaling pathway, Rap1 signaling pathway, Ras signaling pathway, FoxO signaling pathway, thyroid hormone signaling pathway, signaling pathways regulating pluripotency of stem cells, and the Wnt signaling pathway (Table 2) .
Hub node screening and PPI network graph construction of Rhizoma drynariae action on OP Regulation within the body is usually not dominated by a single signaling pathway but rather through a complex regulatory network. Complex crossover networks usually exist between different signaling pathways and targets. Therefore, the active ingredients of a drug not only directly combine with the target, but also combine with other targets in direct and indirect ways. Therefore, the construction of the PPI network and text mining can further explore the direct or indirect regulation relationship between the active ingredients of Rhizoma drynariae and the regulation of OP. Through the construction of the T-T network on the predicted targets of the biological active ingredients of Rhizoma drynariae using BisoGenet, it can be seen that there are 5019 targets that have direct or indirect effects on them, while there are 213 839 correlations between them. There are 13 500 targets directly or indirectly related to osteoporosis, while 523 812 targets are related to each other. Using Cytoscape, the 2 T-T graphs drawn above were extracted and intersected, resulting in a total of 4421 targets and 199 264 correlations. Then, according to the topology of DC, BC, CC, EC, NC, and LAC, CytoNCA was used to obtain 97 hub nodes and 2200 relationships, including 5 putative targets of Rhizoma drynariae and 9 targets of osteoporosis. Among them, 2 targets were common to both and 85 targets did not belong to either, suggesting that bone fragments mainly regulate osteoporosis through indirect targets. The hub node was imported into the string to build the T-T network, as shown in Figure 4 .
Hub node enrichment analysis of OP with Rhizoma drynariae
After G0 enrichment analysis of the hub node through the DAVID database (p<0.05), a total of 139 enrichment results were obtained. These include 80 Biological processes (BP), 32 Molecular functions (MF), and 27 Cellular components (CC). The top 10 enrichment results listed in each category are shown in Figure 2 . The top 20 related signaling pathways, after removal of the extensive pathway of KEGG pathway enrichment, are shown in osteoclast differentiation, Wnt signaling pathway, estrogen signaling pathway, MAPK signaling pathway, FoxO signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, and the cell cycle. Of these, the putative targets of 16 active ingredients of Rhizoma drynariae are directly involved in the estrogen signaling pathway, thyroid hormone signaling pathway, PI3K Akt signaling pathway, cell cycle, FoxO signaling pathway, MAPK signaling pathway, and other OP-related signaling pathways, involving all cells related with the occurrence of osteoporosis, such as osteoblasts, osteoclasts, adipocytes, and bone marrow stromal stem cells. These are also the mainstream pathways of clinical research and drug treatment for OP, indicating that the results of this study are reliable. The anti-OP targets of Rhizoma drynariae are abundant and the mechanism reliability is high ( Figure 5 ).
The main active ingredients of Rhizoma drynariae are docked with key targets
In these 9 KEGG pathways, a total of 36 targets were enriched, in which TP53 frequency and connectivity were the highest. EP300 and RELA appeared frequently and were abundantly expressed in bone marrow. In recent years, the pathogenesis of oxidative stress in OP has attracted more and more attention. STAT3 not only participates in the oxidative stress FoxO pathway, but also acts as a downstream transcription factor to mediate the stress response caused by multiple pathways. The estrogen pathway and thyroid hormone pathway are the main pathways for clinical use of drugs to inhibit bone resorption and promote bone formation. ESR1 is an important target for the treatment of OP and participates in the enrichment of estrogen and thyroid receptor pathways. Osteoblast proliferation 
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plays an important role in improving osteoporosis. CDK2 is an important kinase that regulates the cell cycle and has a high frequency in the enrichment pathway. TRAF appears in the osteoclast differentiation pathway and is upstream of the signaling pathway, which mediates multiple pathways involved in osteoporosis. Therefore, among the 9 main pathways, key targets with high repetition frequency, high clinical research value, and wide coverage were selected: CDK-2, EP300, ESR1, RELA, STAT3, TP53, and TRAF6. Molecular docking validation was conducted on all active ingredients of Rhizoma drynariae. The binding strength was evaluated according to the score, and the mechanism of action was predicted. Binding efficiency is shown in the table below. However, these results need further experimental verification in order to evaluate the reliability of this study and further reveal the active ingredients and the mechanism of action of Rhizoma drynariae (Table 4) .
Discussion
The theory of traditional Chinese medicine is based on systematic medical methodology. It is difficult to fully reveal the mechanisms of the action of traditional Chinese medicine through the study of single ingredients or action targets. It is of great significance to integrate the molecular mechanism of traditional Chinese medicine used in the treatment of diseases through network pharmacology, which is based on big data bioinformatics. Rhizoma drynariae is one of the main drugs used in the treatment of OP with Chinese herbal medicine. The chemical ingredients isolated from Rhizoma drynariae mainly are flavonoids, triterpenoids, phenolic acids, and glycosides. Flavonoids such as naringin can play an anti-osteoporotic role by promoting osteogenesis and inhibiting osteoclast formation [25] , while neoeriocitrin can play a stronger anti-osteoporotic role by promoting osteogenesis [26] . -DQA1  SOX6  WNT3A  CRY2  CER1  TEC   TNFRSF11B  IL17A  CYP1B1  NOS1  MST1R  SLC37A4  GREM2  CASP3   VDR  SERPINE1  NLRP3  NPY  IL37  ZYX  NMUR2  STAT5A   COL1A1  CYP19A1  HSPA5  CDX2  MIR214  MIR503  BMP2K  IRF8   TGFB1  GSTT1  ALDH7A1  CCNE1  PTGER4  GNPTAB  SNX10  INPP5D   TNF  RAP1A  FGF23  WRN  PTN  FRZB  NPNT  S1PR1   ESR1  NPPB  TYMS  SLC34A1  MTNR1B  LGMN  MIR422A  SH3BP2   MTHFR  ICAM1  CD40  ALPL  ITGA1  GALNT3  THSD4  ZMPSTE24   TP53  MIR21  RUNX2  ETS1  UGT2B17  LRRC4C  RNF185  TCIRG1   IL6  HLA-A  VKORC1  POMC  PER3  TSC22D3  DCAF13  HS6ST1   APOE  DKK1  TWIST1  SCG2  EPHB2  MIR449A  FBXO33  CYLD   COL1A2  PIK3CA  CNR1  PTHLH  MEF2C  KDM5A  MIR2861  CRTAP   VEGFA  HLA-DQB1  DPP4  FGF21  INSL3  PLOD1  ZNF410  ACKR1   IGF1  CD44  MMP14  NOX4  ATF6  CA8  IL4  FUT7   IL10  KIT  CNR2  PTK2B  SLC11A2  IL18BP  SP7  XPA   ACE  CALCR  THBS1  SAA1  PLS3  IBSP  LMNA  MIR34C   ADIPOQ  ADRB2  LTA  CX3CL1  MT-TL1  SPRY1  TERT  SLC26A2   APP  CYP1A1  ANXA2  GSN  SLC1A3  FTCDNL1  IL1RN  TPH1   BRCA1  SIRT1  GH1  TGFB2  SATB2  SLC7A7  CTSK  HRAS   NOS3  SPP1  SHBG  JAG1  KAT2A  DOK6  ITGB2  LMNB2   ABCB1  SOD2  IL15  WNT1  G6PC  NMU  CBS  ACTG2   AR  BMP2  AHSG  MIR27A  LEPQTL1  SMS  IGF1  PROK2   AKT1  MAPK3  GC  CTSK  SPP2  PUM1  CALCA  TGIF2   BDNF  SOST  HP  ITLN1  MIR140  DANCR  BGN  RPL5   IL1B  IGF1R  TNFRSF1B  DNM1L  COLEC10  SLC22A11  EIF2AK3  B4GALT7   TLR4  FGF2  BGLAP  PRKAR1A  FSHB  VPS13B  TERC  MTND5   CTNNB1  MBL2  MC4R  ALOX15  AMFR  RXFP2  RECQL2  NOG   CXCL8  IL1A  KL  CCL20  MIR34B  QPCT  MIR34A  CAVIN1   GSTM1  FTO  CCR2  RARRES2  SFRP4  GPR68  POLG  GPR48   SLC6A4  CYP3A4  SPARC  SFRP1  MIR133A1  LGR4  ZAP70  RIN2   TNFSF11  P2RX7  PTH  NOTCH2  MIR23B  GDF11  MYC  GHR   LEP  HGF  TRPV1  CYP27B1  CSTA  TBC1D8  NOTCH1  SERPINA12   HLA-B  RHOA  BMP4  LCT  DVL2  TSPAN12  ERCC2  TYROBP   SLC9A3R1  ALDH2  ITGA2B  IRS2  TUBA1B  XYLT2  HDC  CA10   MTOR  IGF2  LTF  BIRC2  CARTPT  FGFBP1  IL1R1  CCKBR   ESR2  LEPR  SMAD2  IL16  NPY2R  LRP4  MGP  CST3   PON1  STAT1  TRAF6  OSBPL1A  ANKH  ATP6V1H  ITGAV   CCL2  ALB  HSD11B1  LRP6  P2RX4  THSD7A  PPP3CA   BRCA2  MMP3  ADORA2A  CD47  MCM6  ARHGEF3  NFKB1   MMP2  CYP17A1  TNFRSF11A  PDLIM4  WNK4  SQOR  BTK   Table 2 . Known related targets of OP. After enrichment analysis of the predicted targets of the active ingredients of the bone-crushing tonic, the main signaling pathways related to osteoporosis were found to include: nitrogen metabolism, ovarian steroidogenesis and serotonergic synapses, calcium signaling pathway, cell cycle, estrogen signaling pathway, inflammatory signaling pathways, and other pathways closely related to the occurrence and development of OP. This suggests that Rhizoma drynariae may have a variety of active ingredients that prevent osteoporosis through multiple pathways.
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The KEGG enrichment analysis of the hub node further revealed that Rhizoma drynariae can regulate stem cells, osteoblasts, osteoclasts, and immune cells through multiple pathways, including proliferation, differentiation, immunity, and oxidative stress. GO enrichment analysis showed that Rhizoma drynariae can play an anti-osteoporotic role through the bi-directional regulation of upstream transcription processes, promoting an osteogenic differentiation of cells, and regulating cell proliferation and apoptosis, but its bi-directional regulation mechanism still needs further experimental verification. After the KEGG enrichment analysis, it was found that relevant molecular mechanisms were mainly concentrated in 3 categories of pathways related to cell proliferation and differentiation, immune, and inflammation pathways, with the main pathway being the classical Wnt signaling pathway, which plays a dual role in osteoblast and osteoclast differentiation [27] . Increased levels of oxidative stress induced by various factors can promote osteoclast activity, inhibit osteoblastic activity, and promote apoptosis of bone cells [28, 29] . Experiments have proven that the FoxO pathway plays an important role in the anti-oxidative stress response of osteoblasts [30] . However, its antagonistic 5710 Wnt signal increases with age [31] . On one hand, the decrease in estrogen will lead to an increase of osteoclasts and osteoclastic activity; on the other hand, it can promote the secretion of inflammatory factors, such as that of the interleukin and tumor necrosis factor (TNF) family, further promoting bone resorption, and affecting the balance of the RANKL-RANK-OPG axis, leading to increased osteoclast differentiation and activation of osteoclastic activity [32] . Rap1 is critical for resorptive function, and its selective inhibition in mature osteoclasts retards pathological bone loss [33] . In vivo and in vitro studies indicate that the PI3K/Akt cell signaling pathway is involved in the inhibition of osteoporosis by promoting osteoblast proliferation, differentiation, and bone formation [34] . Activated MAPK is involved in physiological processes such as cell proliferation, differentiation, migration, apoptosis, and stress response. It has been found that the ERK1/2 pathway, JNK pathway, and P38 pathway play important roles in increasing osteoblastic generation, reducing osteoclast differentiation, and anti-osteoporotic activity [35] [36] [37] . Studies have shown that thyroid hormones increase bone turnover in the body and promote osteogenesis, but stimulate bone resorption in vitro [38, 39] . The reninangiotensin system (RAS) also plays an important role in the regulation of bone metabolism in osteoporosis [40, 41] . These studies all indicate that Rhizoma drynariae can act on OP at multiple levels through multiple mainstream signaling pathway networks that are mediated by direct or indirect targets. Furthermore, the advantages of Rhizoma drynariae in the treatment of osteoporosis and its potential in new drug development are further illustrated by this study.
Molecular docking is a quick method of predicting binding strength between TCM ingredients and targets based on the spatial structure of ligands and receptors. SystemsDock [20] online docking software uses a docking score to evaluate the binding strength of molecules, and a number from 0 to 10 indicates binding strength from weak to strong. In the signaling pathway network, cross-linking or key nodes often play an important role in mediation. Through screening and integration of hub nodes, related signal pathways, and OP experimental research, we screened out CDK2, ESR1, EP300, RELA, TRAF6, TP53, and STAT3 by performing computer simulations of molecular docking in order to verify the enrichment pathway and T-T network. The docking results show that multiple active ingredients of Rhizoma drynariae have a tight binding strength on the hub nodes, which further indicates that the anti-OP mechanism of Rhizoma drynariae is diverse and active. Estrogen deficiency is the main factor leading to PMOP, and existing estrogen-like drugs are important in the treatment of OP. Genome-wide association studies have also revealed that ESR1 may be a key gene that is highly associated with osteoporosis [42] . The docking results show that many ingredients of Rhizoma drynariae have high binding strength with estrogen receptors, suggesting that Rhizoma drynariae may have estrogen-like effects. Existing research has also confirmed that naringin in Rhizoma drynariae extract can promote osteogenesis through estrogen receptor stimulation [43] , which also further confirms the reliability of this study. Cyclin-dependent kinases (Cdks) are a family of serine/threonine kinases that are key regulators of transcription processes underling coordinated cell cycle entry and sequential progression in nearly all types of proliferative cells [44] , and can be combined with Cyclin. To play a role in regulating the proliferation cycle of osteoblasts, multiple active ingredients of Rhizoma drynariae bind tightly to CDK2, and it is speculated that this promotes osteoblast proliferation by increasing the expression of CDK2 in osteoblasts. EP300 is highly expressed in bone marrow and may be involved in the regulation of cell osteogenic differentiation and osteopenia through chromatin remodeling. It has also been found to be regulated by BMP2 and BMP7 in nucleus pulposus cells, which may be closely related to the occurrence of osteoporosis [45, 46] . Studies have shown that Rhizoma drynariae not only has an anti-OP effect, but can also improve the degeneration of nucleus pulposus cells, which can influence the expression of EP300. Increased nuclear transcription factor kappa B (NF-kB) signaling activity can induce osteoclast differentiation gene expression and increase osteoclast activity and bone resorption [47, 48] . RELA belongs to the NF-kB family and is abundant in bone marrow. It has been found that plastin 3 (PLS3) mutation can significantly enhance susceptibility to osteoporosis and postmenopausal osteoporosis in the elderly, while the upregulation of RELA (NFkB subunit p65) in PLS3-overexpressing mice is known to stimulate osteoclastogenesis, but strikingly reduces osteoclast resorption [49] . Multiple ingredients of Rhizoma drynariae have strong binding capacity with RELA, suggesting that its mechanism of improving osteoporosis may be related to inhibiting the expression of RELA and inhibiting the activity of osteoclasts. The TRAF (TNF receptor associated factor) family of molecules, as intracellular adaptor proteins, are involved in various biological processes such as bone metabolism, immunity, and stress response. TRAF6 may be involved in inducing the activation of NF-kB, thereby promoting osteoporosis [50] . Studies have found that TP53 plays a role in regulating tissue aging [51] , while p53 induces cell cycle arrest during aging [52] , and the activation of autophagy can restore degenerative properties of aged BMMSCs via regulating p53 expression [53] . STAT3 is a member of the STAT family and acts as a downstream target of multiple pathways such as MAPK, MTOR, and JAK. It can be stimulated by upstream signaling molecules such as IL5, IL6, and BMP2 to act as a transcription factor to mediate the expression of various genes in cell growth and cell death. It plays a key role in the process of cell death. The activation of STAT3 can promote upregulation of Runx2 and ALP and decrease the expression of DKK1 [54] , suggesting that some active ingredients in Rhizoma drynariae may be specific ligands for regulating STAT3 expression.
BP (Biological process)
Due to the complexity of Chinese native medicine ingredients and limitations in experimental research methods, there is at present a lack of relevant research reports on the effect of the ingredients of Rhizoma drynariae on the targets and its activity of treating OP alone. However, this study shows that it is valuable to use network pharmacology and molecular docking technology to screen for the active ingredients of traditional Chinese medicines and predict their relevant mechanisms of action. Multiple targets and multiple pathways that play a role in OP were used to decipher, for the first time, the possible molecular mechanisms of Rhizoma drynariae. This work shows the holistic characteristics of OP treated with Rhizoma drynariae. According to the docking results of SystemsDock, the active chemical ingredients were filtered, which provided the basis for subsequent research. The medicinal ingredients with a high score obtained by screening can provide a scientific and practical basis for the establishment of a multi-index quantitative fingerprint and improvement of the quality evaluation of compound ingredients.
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